145 related articles for article (PubMed ID: 22933107)
1. Manganese-enhanced magnetic resonance imaging detects declining pancreatic β-cell mass in a cyclophosphamide-accelerated mouse model of type 1 diabetes.
Antkowiak PF; Stevens BK; Nunemaker CS; McDuffie M; Epstein FH
Diabetes; 2013 Jan; 62(1):44-8. PubMed ID: 22933107
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive assessment of pancreatic beta-cell function in vivo with manganese-enhanced magnetic resonance imaging.
Antkowiak PF; Tersey SA; Carter JD; Vandsburger MH; Nadler JL; Epstein FH; Mirmira RG
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E573-8. PubMed ID: 19116376
[TBL] [Abstract][Full Text] [Related]
3. Quantitative pancreatic β cell MRI using manganese-enhanced Look-Locker imaging and two-site water exchange analysis.
Antkowiak PF; Vandsburger MH; Epstein FH
Magn Reson Med; 2012 Jun; 67(6):1730-9. PubMed ID: 22189705
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes.
Augstein P; Elefanty AG; Allison J; Harrison LC
Diabetologia; 1998 Nov; 41(11):1381-8. PubMed ID: 9833948
[TBL] [Abstract][Full Text] [Related]
5. Manganese-mediated MRI signals correlate with functional β-cell mass during diabetes progression.
Meyer A; Stolz K; Dreher W; Bergemann J; Holebasavanahalli Thimmashetty V; Lueschen N; Azizi Z; Khobragade V; Maedler K; Kuestermann E
Diabetes; 2015 Jun; 64(6):2138-47. PubMed ID: 25804940
[TBL] [Abstract][Full Text] [Related]
6. Histopathological changes in insulin, glucagon and somatostatin cells in the islets of NOD mice during cyclophosphamide-accelerated diabetes: a combined immunohistochemical and histochemical study.
Reddy S; Pathipati P; Bai Y; Robinson E; Ross JM
J Mol Histol; 2005 May; 36(4):289-300. PubMed ID: 16200462
[TBL] [Abstract][Full Text] [Related]
7. Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice.
Balasa B; Lee J; Sarvetnick N
Cell Immunol; 1999 May; 193(2):170-8. PubMed ID: 10222059
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive imaging of functional pancreatic islet beta-cell mass in people with type 1 diabetes mellitus.
Joshi SS; Singh T; Kershaw LE; Gibb FW; Dweck MR; Williams M; Idris I; Semple S; Forbes S; Newby DE; Reynolds RM
Diabet Med; 2023 Oct; 40(10):e15111. PubMed ID: 37035965
[TBL] [Abstract][Full Text] [Related]
9. Insulin-producing intestinal K cells protect nonobese diabetic mice from autoimmune diabetes.
Mojibian M; Lam AW; Fujita Y; Asadi A; Grassl GA; Dickie P; Tan R; Cheung AT; Kieffer TJ
Gastroenterology; 2014 Jul; 147(1):162-171.e6. PubMed ID: 24662331
[TBL] [Abstract][Full Text] [Related]
10. Fas and Fas ligand immunoexpression in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
Reddy S; Ross JM
Ann N Y Acad Sci; 2003 Nov; 1005():166-9. PubMed ID: 14679052
[TBL] [Abstract][Full Text] [Related]
11. Unexpected acceleration of type 1 diabetes by transgenic expression of B7-H1 in NOD mouse peri-islet glia.
Yantha J; Tsui H; Winer S; Song A; Wu P; Paltser G; Ellis J; Dosch HM
Diabetes; 2010 Oct; 59(10):2588-96. PubMed ID: 20522597
[TBL] [Abstract][Full Text] [Related]
12. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic beta-cells.
Li X; Chen H; Epstein PN
Diabetes; 2006 Jun; 55(6):1592-604. PubMed ID: 16731821
[TBL] [Abstract][Full Text] [Related]
14. The effect of cyclophosphamide treatment on lymphocyte subsets in the nonobese diabetic mouse: a comparison of various lymphoid organs.
Zhang ZL; Georgiou HM; Mandel TE
Autoimmunity; 1993; 15(1):1-10. PubMed ID: 8218826
[TBL] [Abstract][Full Text] [Related]
15. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.
Kim S; Kim HS; Chung KW; Oh SH; Yun JW; Im SH; Lee MK; Kim KW; Lee MS
Diabetes; 2007 Oct; 56(10):2561-8. PubMed ID: 17620422
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of caspase-3-expressing cells within the pancreas of non-obese diabetic mice during cyclophosphamide-accelerated diabetes.
Reddy S; Bradley J; Ginn S; Pathipati P; Ross JM
Histochem Cell Biol; 2003 Jun; 119(6):451-61. PubMed ID: 12802593
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the preservation effect of canagliflozin on pancreatic beta cell mass using SPECT/CT imaging with
Hamamatsu K; Fujimoto H; Fujita N; Murakami T; Shiotani M; Toyoda K; Inagaki N
Sci Rep; 2019 Dec; 9(1):18338. PubMed ID: 31797889
[TBL] [Abstract][Full Text] [Related]
18. High-resolution magnetic resonance imaging quantitatively detects individual pancreatic islets.
Lamprianou S; Immonen R; Nabuurs C; Gjinovci A; Vinet L; Montet XC; Gruetter R; Meda P
Diabetes; 2011 Nov; 60(11):2853-60. PubMed ID: 21926272
[TBL] [Abstract][Full Text] [Related]
19. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging.
Cline GW; Naganawa M; Chen L; Chidsey K; Carvajal-Gonzalez S; Pawlak S; Rossulek M; Zhang Y; Bini J; McCarthy TJ; Carson RE; Calle RA
Diabetologia; 2018 Dec; 61(12):2598-2607. PubMed ID: 29721633
[TBL] [Abstract][Full Text] [Related]
20. Biphasic decline of β-cell function with age in euglycemic nonobese diabetic mice parallels diabetes onset.
Cechin SR; Lopez-Ocejo O; Karpinsky-Semper D; Buchwald P
IUBMB Life; 2015 Aug; 67(8):634-44. PubMed ID: 26099053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
